Clinical Trials
43 trialsA Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
National Cancer Institute (NCI)
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Massachusetts General Hospital
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Virginia Commonwealth University
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
ALASCCA
Karolinska Institutet
A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
University of Michigan Rogel Cancer Center
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
M.D. Anderson Cancer Center
ASPIRED
Massachusetts General Hospital
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Fox Chase Cancer Center
ASAC
Oslo University Hospital
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
University College, London
Adjuvant Aspirin Treatment for Colon Cancer Patients
Swiss Cancer Institute
AspECT
University of Oxford
Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer
Instituto de Investigación Sanitaria Aragón
Molecular Effects of Aspirin & Metformin on Colonic Epithelium
University of Edinburgh
EASTERN
National Cancer Center, Korea
REPROGRAM-01
Centre Hospitalier Universitaire de Besancon
REPROGRAM-02
Centre Hospitalier Universitaire de Besancon
ASPIRIN
University Hospital, Antwerp
ASPIRIN
Leiden University Medical Center
ASCOLT
National Cancer Centre, Singapore
ASAP
German Cancer Research Center
Trial of Aspirin and Arginine Restriction in Colorectal Cancer
University of California, Irvine
The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study
University of Calgary
Low-dose Aspirin Therapy for Esophageal Cancer
Zhejiang University
ICAR
Instituto Nacional de Cancer, Brazil
Aspirin/Folate Prevention of Large Bowel Polyps
Dartmouth-Hitchcock Medical Center
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
Fudan University
Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma
Fudan University
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
National Cancer Institute (NCI)
CaPP3 Israel
Tel-Aviv Sourasky Medical Center
Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Alliance for Clinical Trials in Oncology
APREMEC
The Fourth Affiliated Hospital of Anhui Medical University
ACABC
Zhejiang Provincial People's Hospital
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action
Aragon Institute of Health Sciences
Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
National Cancer Institute (NCI)
Physiological Effects of Altering Cancer-related Inflammation
NHS Greater Glasgow and Clyde
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
M.D. Anderson Cancer Center
APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence
Assistance Publique - Hôpitaux de Paris
ASAPOL
Maria Sklodowska-Curie National Research Institute of Oncology
Barrett's Esophagus - 315 - 3 Way Cross Over
AstraZeneca